We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Surgery Rebuilds Mandible Following Tumor Surgery

By HospiMedica International staff writers
Posted on 01 Nov 2012
A novel surgical approach helps rebuild a functional lower jaw and mouth and preserve the ability to eat and speak after removing an invasive facial tumor, according to a new study.

Researchers at Henry Ford Hospital (Detroit, MI, USA) described a case of a 21-year-old African American male with a history of osteosarcoma that had spread to his lower jawbone three years after the initial diagnosis. More...
The facial tumor soon grew to nearly 4.5 kg of tissue and bone, making it difficult for him to speak and eat, eventually requiring a feeding tube. The patient had previously undergone multiple treatments, including mandible resection, radiation, chemotherapy, and cryosurgery; all treatments were unsuccessful.

The surgeons at Henry Ford Hospital performed a near total mandibulectomy and removal of the tongue and mucous membrane from the inside of both cheeks and lower lip. The complex reconstruction of the face and jaw was then undertaken using dual microvascular free flaps from the left fibula and the subscapular area, a versatile donor system that offers mobility and a diverse range of skin, bone, and muscle available for use in reconstruction of massive facial defects. The study describing the procedure was presented as a poster session at the American Academy of Facial Plastic and Reconstructive Surgery annual meeting, held during September 2102 in Washington DC (USA).

“The bone tumor involved nearly all of his jaw bone, lower lip, chin, neck skin, tongue and both cheeks, approximately the lower third of the face and upper half of his neck,” said senior author and study presenter Tamer Ghanem, MD, PhD., director of the head and neck oncology and microvascular surgery division. “We had to think outside the box to not only safely remove the tumor, but to allow for optimum functional outcome.”

The researcher reported that only three months after the surgery the patient was able to talk and eat without assistance.

Related Links:
Henry Ford Hospital



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Wound Irrigation Solution
Prontosan®
New
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.